136 related articles for article (PubMed ID: 19149768)
1. TLRs antiviral effect on hepatitis B virus in HepG2 cells.
Xia C; Lu M; Zhang Z; Meng Z; Zhang Z; Shi C
J Appl Microbiol; 2008 Nov; 105(5):1720-7. PubMed ID: 19149768
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of the combination of CpG-induced cytokines with lamivudine against hepatitis B virus replication in vitro.
Vincent IE; Lucifora J; Durantel D; Hantz O; Chemin I; Zoulim F; Trepo C
Antivir Ther; 2009; 14(1):131-5. PubMed ID: 19320247
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effect of HMGN2 protein on human hepatitis B virus expression and replication in the HepG2.2.15 cell line.
Feng Y; He F; Zhang P; Wu Q; Huang N; Tang H; Kong X; Li Y; Lu J; Chen Q; Wang B
Antiviral Res; 2009 Mar; 81(3):277-82. PubMed ID: 19150374
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus suppresses toll-like receptor-mediated innate immune responses in murine parenchymal and nonparenchymal liver cells.
Wu J; Meng Z; Jiang M; Pei R; Trippler M; Broering R; Bucchi A; Sowa JP; Dittmer U; Yang D; Roggendorf M; Gerken G; Lu M; Schlaak JF
Hepatology; 2009 Apr; 49(4):1132-40. PubMed ID: 19140219
[TBL] [Abstract][Full Text] [Related]
5. [Toll-like receptor dependent innate immune responses by primary mouse hepatocytes and its control of HBV replication].
Wu J; Chen MF; Xia YC; Guo Y; Lin Y; Sun C; Zhang CY; Chen Y; Liu SP; Hao YH; Lu MJ; Schlaak JF; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):838-42. PubMed ID: 22433306
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the innate immune signalling pathways in hepatocyte cell lines.
Preiss S; Thompson A; Chen X; Rodgers S; Markovska V; Desmond P; Visvanathan K; Li K; Locarnini S; Revill P
J Viral Hepat; 2008 Dec; 15(12):888-900. PubMed ID: 18673429
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides targeted against asialoglycoprotein receptor 1 block human hepatitis B virus replication.
Yang J; Bo XC; Ding XR; Dai JM; Zhang ML; Wang XH; Wang SQ
J Viral Hepat; 2006 Mar; 13(3):158-65. PubMed ID: 16475991
[TBL] [Abstract][Full Text] [Related]
8. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
9. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg].
Li YW; Yang HZ; Ke QS; Chen W; Chen XJ
Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248
[TBL] [Abstract][Full Text] [Related]
10. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease.
Kladney RD; Cui X; Bulla GA; Brunt EM; Fimmel CJ
Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of STAT1 methylation is involved in the resistance of hepatitis B virus to Interferon alpha.
Li J; Chen F; Zheng M; Zhu H; Zhao D; Liu W; Liu W; Chen Z
Antiviral Res; 2010 Mar; 85(3):463-9. PubMed ID: 19857525
[TBL] [Abstract][Full Text] [Related]
12. Expression of Toll-like receptors in chronic hepatitis C virus infection.
Sato K; Ishikawa T; Okumura A; Yamauchi T; Sato S; Ayada M; Matsumoto E; Hotta N; Oohashi T; Fukuzawa Y; Kakumu S
J Gastroenterol Hepatol; 2007 Oct; 22(10):1627-32. PubMed ID: 17845690
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice.
Wu J; Lu M; Meng Z; Trippler M; Broering R; Szczeponek A; Krux F; Dittmer U; Roggendorf M; Gerken G; Schlaak JF
Hepatology; 2007 Dec; 46(6):1769-78. PubMed ID: 17929296
[TBL] [Abstract][Full Text] [Related]
14. [An in vitro model of hepatitis B virus gene replication and expression in primary rat hepatocytes transfected with circular viral DNA].
Yao YQ; Zhang DF; Luo Y; Zhang DZ; Huang AL; Wang B; Zhou WP; Ren H; Guo SH
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):275-8. PubMed ID: 12223138
[TBL] [Abstract][Full Text] [Related]
15. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of indoleamine 2,3-dioxygenase in hepatocyte during acute hepatitis caused by hepatitis B virus-specific cytotoxic T lymphocytes in vivo.
Iwamoto N; Ito H; Ando K; Ishikawa T; Hara A; Taguchi A; Saito K; Takemura M; Imawari M; Moriwaki H; Seishima M
Liver Int; 2009 Feb; 29(2):277-83. PubMed ID: 18397228
[TBL] [Abstract][Full Text] [Related]
17. Control of hepatitis B virus replication by innate response of HepaRG cells.
Lucifora J; Durantel D; Testoni B; Hantz O; Levrero M; Zoulim F
Hepatology; 2010 Jan; 51(1):63-72. PubMed ID: 19877170
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
19. [Effect of cell cycle on telomerase activity of hepatoma cells and its relationship with replication of hepatitis B virus].
Yan SN; Deng B; Gong ZJ
Ai Zheng; 2003 May; 22(5):504-7. PubMed ID: 12753712
[TBL] [Abstract][Full Text] [Related]
20. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
